Tango Therapeutics, Inc.
TNGX
$10.08
-$0.34-3.26%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 18.54% | -24.96% | -18.46% | -28.07% | -23.34% |
| Total Depreciation and Amortization | -2.96% | 0.08% | 1.50% | 3.48% | 5.41% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 21.31% | 22.93% | 37.39% | 45.23% | 19.12% |
| Change in Net Operating Assets | -202.76% | -15.24% | -5.50% | 16.38% | 38.46% |
| Cash from Operations | -19.21% | -23.48% | -11.91% | -11.46% | -2.98% |
| Capital Expenditure | -10.98% | -20.74% | 44.60% | 50.59% | 63.43% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 115.00% | 746.52% | 56,723.79% | 102.27% | 2,656.65% |
| Cash from Investing | 116.31% | 719.28% | 9,732.98% | 107.90% | 1,449.99% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -91.54% | -96.87% | -96.27% | -42.33% | -40.59% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -91.50% | -96.86% | -96.26% | -42.16% | -40.88% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 183.16% | 19.87% | -189.39% | -60.87% | 85.26% |